Position in SIGA
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$401
New position
Shares Held
75
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bell Investment Advisors, Inc holds $111,986 across 20 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
41 | $22,215 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,005 | $14,562 | |
| 3 | HCM |
HUTCHMED (China) Ltd
|
1,015 | $10,921 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
488 | $7,822 | |
| 5 | VTRS |
Viatris Inc
|
454 | $7,209 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
41 | $6,910 | |
| 7 | ZTS |
Zoetis Inc.
|
94 | $6,754 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
264 | $6,497 |
All Filings in SIGA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $401 | 75 | Shares | Sole | 2026-04-17 | |
| No filing history on record for this holder in this stock. | ||||||